Table 4.
SARS-CoV-2 cohort 2.
| Characteristics | ICU | Severe | Mild | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of patients | 16 | 7 | 16 | ||||||
| Median age (range) | 47.25 (18–74) | 63.29 (47–83) | 47.75 (23–72) | ||||||
| Sex (female/male) | 3/13 | 3/4 | 12/4 | ||||||
| Median BMI (range) | 29.26 (19.7–42.6) | 27.28 (23.2–30.5) | 24.11 (17.4–29.7) | ||||||
| Comorbidities | Lung disease | 2 | Lung disease | 0 | Lung disease | 1 | |||
| Heart disease | 3 | Heart disease | 3 | Heart disease | 0 | ||||
| Diabetes mellitus | 4 | Diabetes mellitus | 1 | Diabetes mellitus | 0 | ||||
| Adiposities | 6 | Adiposities | 1 | Adiposities | 0 | ||||
| Immunosuppression | 1 | 0 | 0 | ||||||
| Glucocorticoids | 3 | 0 | 0 | ||||||
| Remdesivir | 7 | 0 | 0 | ||||||
| Smoker status | Never | 11 | Never | 4 | Never | 5 | |||
| Former | 5 | Former | 3 | Former | 10 | ||||
| Active | 0 | Active | 0 | Active | 0 | ||||
| Fatigue status | T2 | No | 4 | T2 | No | 0 | T2 | No | 2 |
| Mild | 3 | Mild | 2 | Mild | 0 | ||||
| Extreme | 2 | Extreme | 2 | Extreme | 1 | ||||
| T3 | No | 6 | T3 | No | 2 | T3 | No | 6 | |
| Mild | 6 | Mild | 3 | Mild | 7 | ||||
| Extreme | 0 | Extreme | 1 | Extreme | 2 | ||||
| T4 | No | 9 | T4 | No | 4 | T4 | No | 7 | |
| Mild | 5 | Mild | 2 | Mild | 7 | ||||
| Extreme | 1 | Extreme | 1 | Extreme | 2 | ||||
| T5 | No | 5 | T5 | No | 3 | T5 | No | 1 | |
| Mild | 3 | Mild | 1 | Mild | 4 | ||||
| Extreme | 3 | Extreme | 0 | Extreme | 2 | ||||
| Median FEV1% (range) | T2 | 88.9 (68–107) | T2 | 105.8 (96–114) | T2 | 98 (92–103) | |||
| T3 | 87.6 (55–105) | T3 | 103.5 (94–110) | T3 | 98.9 (78–122) | ||||
| T4 | 92.3 (51–131) | T4 | 102.4 (86–116) | T4 | 97.8 (69–123) | ||||
| T5 | 86.3 (58–106) | T5 | 89 (79–99) | T5 | 94.9 (79–115) | ||||